Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

• Main Authors: Rongmeng Jiang (Author), Bing Han (Author), Meihua Song (Author), Bing Xue (Author), Yongxiang Zhang (Author), Yanyan Ding (Author), Jin Chen (Author), Jing Zhu (Author), Jianhua Liu (Author), Qingrong Nie (Author), Xuefeng Han (Author), Xiuhong Jin (Author), Xiaoyin Shan (Author), Weian Guo (Author), Erming Zhang (Author), Zuoqing Zhang (Author), Changhong Zhang (Author), Jie Zhang (Author), Baozeng Wang (Author), Shuwen Dong (Author), Jiandong Li (Author), Xiaoguang Li (Author), Xingwang Li (Author)
• Format: Book
• Published: BMC, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background To investigate the efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia. Methods One hundred sixty-four patients with noninfluenza viral pneumonia were divided into IFNα1b and control groups. The IFNα1b...